Andrew Krakauer, Cantel Medical president and CEO, said: “The stock split reflects our confidence in the future operating results and cash flows of the company, as well as our ongoing determination to build long-term shareholder value. The stock split will increase the float and provide greater liquidity for shareholders.”
 
The Cantel Medical product range includes hollow fibre membrane filtration and separation products for medical and non-medical applications.